Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)

Merck Sharp & Dohme LLC · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
melanoma
melanoma, programmed cell death-1 (pd-1), programmed cell death 1 (pd1), programmed cell death-ligand 1 (pd-l1, pdl1), programmed cell death-ligand 2 (pd-l2, pdl2), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 846086
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.